tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools30% OFF!
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ALLR Stock Latest News

Allarity regains compliance with Nasdaq minimum stockholder equity requirement
The FlyAllarity regains compliance with Nasdaq minimum stockholder equity requirement
13d ago
ALLR
Allarity Therapeutics Regains Compliance with Nasdaq’s Minimum Stockholders’ Equity Requirement
PremiumPress Releases
Allarity Therapeutics Regains Compliance with Nasdaq’s Minimum Stockholders’ Equity Requirement
13d ago
ALLR
Allarity reports Q1 net loss $3.8M vs. $3.4M last year
PremiumThe Fly
Allarity reports Q1 net loss $3.8M vs. $3.4M last year
19d ago
ALLR
Allarity Therapeutics Reports First Quarter Financial Results and Highlights, including Clear Clinical Benefits from Phase 2 Trial, NASDAQ Compliance, and Significant Improvement in Cash and Equity Balances
PremiumPress Releases
Allarity Therapeutics Reports First Quarter Financial Results and Highlights, including Clear Clinical Benefits from Phase 2 Trial, NASDAQ Compliance, and Significant Improvement in Cash and Equity Balances
19d ago
ALLR
Allarity Therapeutics Restructures Capital and Reduces Debt
PremiumCompany Announcements
Allarity Therapeutics Restructures Capital and Reduces Debt
24d ago
8K
ALLR
Allarity Therapeutics Announces that All Series A Preferred and All Variable Priced Warrants have Converted to Common Stock
PremiumPress ReleasesAllarity Therapeutics Announces that All Series A Preferred and All Variable Priced Warrants have Converted to Common Stock
26d ago
ALLR
Allarity Therapeutics Anticipates Nasdaq Compliance, Withdraws S-1 Filing
PremiumCompany Announcements
Allarity Therapeutics Anticipates Nasdaq Compliance, Withdraws S-1 Filing
27d ago
8K
ALLR
Allarity exceeds Nasdaq’s minimum equity requirement
PremiumThe Fly
Allarity exceeds Nasdaq’s minimum equity requirement
27d ago
ALLR
Allarity Therapeutics Exceeds Nasdaq’s Minimum Equity Requirement; Requests Voluntarily Withdrawal of Form S-1
PremiumPress Releases
Allarity Therapeutics Exceeds Nasdaq’s Minimum Equity Requirement; Requests Voluntarily Withdrawal of Form S-1
27d ago
ALLR
Allarity Therapeutics’ Stenoparib Shows Promise in Ovarian Cancer Trial
PremiumCompany Announcements
Allarity Therapeutics’ Stenoparib Shows Promise in Ovarian Cancer Trial
30d ago
8K
ALLR
Allarity announces early discontinuation of Phase 2 trial of stenoparib
PremiumThe Fly
Allarity announces early discontinuation of Phase 2 trial of stenoparib
1M ago
ALLR
Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer
PremiumPress Releases
Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer
1M ago
ALLR
Allarity Therapeutics Maintains NASDAQ Compliance with Bid Price
PremiumCompany AnnouncementsAllarity Therapeutics Maintains NASDAQ Compliance with Bid Price
1M ago
8K
ALLR
Allarity regains compliance with NASDAQ minimum bid price requirement
PremiumThe Fly
Allarity regains compliance with NASDAQ minimum bid price requirement
1M ago
ALLR
Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement
PremiumPress Releases
Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement
1M ago
ALLR
Allarity Therapeutics Granted Extension for Nasdaq Compliance
PremiumCompany Announcements
Allarity Therapeutics Granted Extension for Nasdaq Compliance
1M ago
8K
ALLR
Allarity Therapeutics Receives NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)(1)
PremiumPress Releases
Allarity Therapeutics Receives NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)(1)
2M ago
ALLR
Allarity receives extension from Nasdaq to regain compliance
PremiumThe Fly
Allarity receives extension from Nasdaq to regain compliance
2M ago
ALLR
Allarity Therapeutics Inc trading halted, news pending
PremiumThe Fly
Allarity Therapeutics Inc trading halted, news pending
2M ago
ALLR
Allarity Therapeutics Announces Upcoming Reverse Stock Split
PremiumCompany AnnouncementsAllarity Therapeutics Announces Upcoming Reverse Stock Split
2M ago
8K
ALLR
Allarity announces 1-for-20 reverse stock split
PremiumThe Fly
Allarity announces 1-for-20 reverse stock split
2M ago
ALLR
Allarity Therapeutics Announces 1-for-20 Reverse Stock Split
PremiumPress Releases
Allarity Therapeutics Announces 1-for-20 Reverse Stock Split
2M ago
ALLR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >